The head of the biggest medical device lobby group says the organization has had to shift its focus to prioritize the ongoing COVID-19 pandemic. Some issues that have had to take a back seat as industry addresses the current crisis include the upcoming user-fee negotiations, anti-kickback legislation and breakthrough technologies reform.
Scott Whitaker, president and CEO of AdvaMed, told Medtech Insight on 14 April that while his organization has had to...